Managed Account Advisors’s EnteroMedics Inc. ETRM Stock Holding History

Managed Account Advisors’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$26K	Buy	41 +17	+71%	+$19.6K	﹤0.01%	2760
2015 Q1	$23K	Sell	24 -2	-8%	-$2.41K	﹤0.01%	2728
2014 Q4	$39K	Buy	26 +3	+13%	+$4.05K	﹤0.01%	2483
2014 Q3	$30K	Sell	23 -2	-8%	-$2.93K	﹤0.01%	2481
2014 Q2	$41K	Buy	25 +6	+32%	+$11.2K	﹤0.01%	2422
2014 Q1	$37K	Buy	19 +3	+19%	+$7.1K	﹤0.01%	2413
2013 Q4	$35K	Sell	16 -11	-41%	-$17.7K	﹤0.01%	2396
2013 Q3	$36K	Hold	27	–	–	﹤0.01%	2331
2013 Q2	$32K	Buy	+27	New	+$28.5K	﹤0.01%	2333

Other funds holding ETRM

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Managed Account Advisors's ETRM Position: Q2 2015 in Review

Managed Account Advisors increased its EnteroMedics Inc. (ETRM) stake by 71% in Q2 2015, buying an estimated $19.6K and bringing the position to 41 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #2760.

Managed Account Advisors first reported a position in ETRM in Q2 2013 and has held it in 9 quarters since. The position peaked at $41K in Q2 2014. 46 funds tracked by Wall St. Rank hold ETRM as of Q2 2015.

Managed Account Advisors held 41 shares of EnteroMedics Inc. worth $26K as of Q2 2015.
Managed Account Advisors bought 17 EnteroMedics Inc. shares in Q2 2015, an estimated $19.6K.
EnteroMedics Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2760 holding.
Managed Account Advisors first reported a position in EnteroMedics Inc. in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's EnteroMedics Inc. position peaked at $41K in Q2 2014.
46 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.